Skip to main content
OpenTrials
Completed

NCT Number: NCT01773057

Effects of 'NHGDoc' on Quality of Care

The purpose of this study is to determine whether the computerized decision support system 'NHGDoc' is effective in improving quality of primary care in terms of processes of care (e.g. prescribing behavior of physicians) as well as outcomes of care (e.g. hospital admissions, mortality).

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Radboud University Nijmegen Medical Centre, IQ healthcare

Nijmegen, 6500 HB, Netherlands

About this study

Computerized decision support systems are regarded as useful tools to improve quality of care, but their effects are still uncertain. In the Netherlands 'NHGDoc' a computerized decision support system supported by the Dutch College of General Practitioners (NHG) is currently being implemented among more than 1.000 general practices in the Netherlands.

The aim of this study is to evaluate the effects of NHGDoc on quality of care. In addition, we want to gain insight into the barriers and facilitators that affect the systems' impact.

A cluster randomized controlled trial will be conducted among 120 general practices in the Netherlands. Eligible practices will be randomized to receive either the regular NHGDoc modules (control arm) or the regular modules and an additional module on heart failure (intervention arm). The effect evaluation will focus on processes of care (e.g. prescription behavior) as well as on patient outcomes (e.g. hospital admissions, mortality). Additionally, a process evaluation will be conducted, which includes a focus group study and a survey among participating healthcare providers to evaluate the perceived barriers and facilitators to using 'NHGDoc'.

Results of this study will provide insight in the ability of computerized decision support systems and in particular 'NHGDoc' to improve quality of primary care. Whereas the trial focuses on a specific NHGDoc domain - heart failure - we believe our conclusions are relevant to other primary care areas as well, particularly as this study also explores the factors that contribute to the systems' effectiveness.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • General practices should use the information system MicroHIS X or Promedico ASP
  • NHGDoc should be available in the general practices

Exclusion criteria

  • General practices that do not meet the inclusion criteria

Treatment and study plan

NHGDoc domain Heart Failure

Other

Healthcare providers receive patient specific alerts in terms of diagnosing and treatment of patients with heart failure

Primary outcomes

  1. Prescribing of ACE-inhibitors/Angiotensin II

    Time frame: One year

    Percentage of patients with heart failure that is prescribed ACE-inhibitors/Angiotensin II

  2. Prescribing of beta blockers

    Time frame: One year

    Percentage of heart failure patients that is prescribed beta blockers

  3. Prescribing of diuretics

    Time frame: One year

    Percentage of heart failure patients that is prescribed diuretics

Secondary outcomes

  1. Hospital admissions

    Time frame: One year

    Number of hospital admissions of patients with heart failure

  2. All cause mortality

    Time frame: One year

    Number of patients with heart failure that die within the hospital

Sponsors and collaborators

Lead sponsor

Radboud University Medical Center

Other

Collaborators

  • Netherlands: Ministry of Health, Welfare and Sports

Registry information

Official study title

Effects of the Computerized Decision Support System 'NHGDoc' on Quality of Care: a Cluster Randomized Controlled Trial

Acronym: NHGDoc

Important dates

Study start
2013
Primary completion
2017
Study completion
2017
First posted
Jan 23, 2013
Registry last updated
Apr 12, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.